New study aims to catch Parkinson's and Alzheimer's earlier
NCT ID NCT07467460
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is looking for new, less invasive ways to diagnose and track Parkinson's disease, Alzheimer's disease, and type 2 diabetes. Researchers will study 500 participants using blood tests, brain scans, and genetic analysis to find early signs of these conditions. The goal is to improve understanding and monitoring, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to new ways to detect Parkinson's and Alzheimer's earlier and track their progression more accurately.
- What could go wrong
- This is an observational study, not a treatment trial. It may not directly lead to new therapies, and the findings might not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
IRCCS INM Neuromed
RECRUITINGPozzilli, 86077, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could your brain help unlock Alzheimer's secrets?
- Can a gene therapy clear the toxic tau tangle in Alzheimer's?
- Parkinson's pain: could a new Add-On drug bring relief?
- Can a new drug tame Alzheimer's? early trial aims to find out
- Could your own bone marrow cells help fight Parkinson's?
- A scan that sees Alzheimer's tangles? trial puts tau tracer to the test